Technology News and Research

RSS

RNA sequencing method uncovers new insights into biological events in heart disease

Scientists using a powerful new technology that sequences RNA in 20,000 individual cell nuclei have uncovered new insights into biological events in heart disease.

5 Oct 2018

Predicting blood pressure with wearable off-the-shelf technology

Engineers at UC San Diego used wearable off-the-shelf technology and machine learning to predict, for the first time, an individual's blood pressure and provide personalized recommendations to lower it based on this data.

5 Oct 2018

Krembil scientists develop potential treatment to stop knee and spine osteoarthritis

Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks.

5 Oct 2018

Emissions from gas stations found to be higher than previously thought

A study led by environmental health scientists at Columbia University Mailman School of Public Health examined the release of vapors from gas station vent pipes, finding emissions were 10 times higher than estimates used in setback regulations used to determine how close schools, playgrounds, and parks can be situated to the facilities.

5 Oct 2018

Blackstone to acquire leading life sciences investment firm, Clarus

Blackstone today announced that it has agreed to acquire Clarus, a leading global life sciences investment firm that has raised $2.6 billion since its founding. Clarus, with offices in the life sciences hubs of Boston and San Francisco, is focused on funding growth-stage investments, often in partnership with major biopharmaceutical companies through R&D collaborations.

5 Oct 2018

Clemson University researcher reveals insights into rapid spread of homemade steroids

A Clemson University researcher recently published insights into homemade steroids and steroid trafficking through a study of federal court cases. The research details why homemade steroids became popular and how online tools and cryptocurrency have allowed for their rapid spread.

4 Oct 2018

HalioDx announces availability of Brightplex, a high capacity IHC multiplex technology

HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.

4 Oct 2018

Working with Next Health World Innovation Forum to build a healthier future

The Innovation Forum is partnering with the Milner Therapeutics Institute in 2019 for the Next Health World Innovation Forum – a new international healthcare conference taking place from 26-27 June 2019, in Cambridge, UK.

4 Oct 2018

Ingenza announces extension of collaboration with Syngenta

Industrial biotech specialist Ingenza has announced that its collaboration with Syngenta for work on efficient technologies to support the development of crop protection products has been extended.

4 Oct 2018

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

The married professors were spending their Thanksgiving holiday in Egypt when the husband, Thomas L. Patterson, Ph.D., got very sick very quickly, experiencing fever, nausea and a racing heartbeat. By the time Patterson was accurately diagnosed with a highly multi-drug resistant bacterial infection, he was near death.

4 Oct 2018

Stevens researchers develop new class of molecules for breast cancer treatment

Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.

4 Oct 2018

High-quality hospitals provide lower cost care for 82% of diagnoses, analysis reveals

High-quality hospitals deliver lower-cost care for 82% of diagnoses, according to a new analysis that Advisory Board released today on variations in care that do not improve care costs or patient outcomes.

3 Oct 2018

Special glowing paper strip as rapid, reliable test for infectious diseases

Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

3 Oct 2018

A Single Platform to Sequence All Monoclonal Antibody Proteins

Having a single platform to sequence all monoclonal antibody proteins provides researchers with key information for research, development and drug discovery

From Rapid Novor Inc 3 Oct 2018

Researchers create pseudo-embryos that mimic human embryos

Researchers have created murine pseudo-embryos that form the three major axes of the body and are able to accurately mimic human embryos.

3 Oct 2018

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

A study has shown that hybrid day-night closed-loop insulin delivery systems are the most effective way of controlling blood sugar levels in type 1 diabetes.

3 Oct 2018

New report examines similarities between spacecraft and hospital sterility assurance challenges

In a new report published in Space Policy, Adrian Ponce, Ph.D., of NASA's Jet Propulsion Laboratory and founder of Verrix, and co-authors examine the importance of sterility assurance to prevent contamination of spacecraft destined to potentially habitable ocean worlds of the outer solar system, and the parallel debate around sterility assurance requirements in the healthcare environment.

3 Oct 2018

RCIGM and IDbyDNA launch clinical trial to improve diagnostics for pediatric CNS infections

The Rady Children's Institute for Genomic Medicine and IDbyDNA, a metagenomics technology company translating microbial genomics into actionable information for healthcare providers, have launched a clinical trial to improve diagnostics for pediatric central nervous system infections.

3 Oct 2018

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.

3 Oct 2018

Eagle Pharmaceuticals and USAMRICD signs agreement to assess neuroprotective effects of RYANODEX

Eagle Pharmaceuticals, Inc. today announced that it has entered into an agreement with the United States Army Medical Research Institute of Chemical Defense, the nation's leading science and technology laboratory in the area of medical chemical countermeasures research and development, to conduct a study to evaluate the neuroprotective effects of RYANODEX.

3 Oct 2018

Technology News and Research

RNA sequencing method uncovers new insights into biological events in heart disease

Predicting blood pressure with wearable off-the-shelf technology

Krembil scientists develop potential treatment to stop knee and spine osteoarthritis

Emissions from gas stations found to be higher than previously thought

Blackstone to acquire leading life sciences investment firm, Clarus

Clemson University researcher reveals insights into rapid spread of homemade steroids

HalioDx announces availability of Brightplex, a high capacity IHC multiplex technology

Working with Next Health World Innovation Forum to build a healthier future

Ingenza announces extension of collaboration with Syngenta

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

Stevens researchers develop new class of molecules for breast cancer treatment

High-quality hospitals provide lower cost care for 82% of diagnoses, analysis reveals

Special glowing paper strip as rapid, reliable test for infectious diseases

A Single Platform to Sequence All Monoclonal Antibody Proteins

Researchers create pseudo-embryos that mimic human embryos

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

New report examines similarities between spacecraft and hospital sterility assurance challenges

RCIGM and IDbyDNA launch clinical trial to improve diagnostics for pediatric CNS infections

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Eagle Pharmaceuticals and USAMRICD signs agreement to assess neuroprotective effects of RYANODEX

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News